Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family

Atherosclerosis. 2017 Sep:264:58-66. doi: 10.1016/j.atherosclerosis.2017.07.024. Epub 2017 Jul 22.

Abstract

Background and aims: Hypercholesterolemia confers susceptibility to cardiovascular disease (CVD). Both serum total cholesterol (TC) and LDL-cholesterol (LDL-C) exhibit a strong genetic component (heritability estimates 0.41-0.50). However, a large part of this heritability cannot be explained by the variants identified in recent extensive genome-wide association studies (GWAS) on lipids. Our aim was to find genetic causes leading to high LDL-C levels and ultimately CVD in a large Austrian family presenting with what appears to be autosomal dominant inheritance for familial hypercholesterolemia (FH).

Methods: We utilized linkage analysis followed by whole-exome sequencing and genetic risk score analysis using an Austrian multi-generational family with various dyslipidemias, including elevated TC and LDL-C, and one family branch with elevated lipoprotein (a) (Lp(a)).

Results: We did not find evidence for genome-wide significant linkage for LDL-C or apparent causative variants in the known FH genes rather, we discovered a particular family-specific combination of nine GWAS LDL-C SNPs (p = 0.02 by permutation), and putative less severe familial hypercholesterolemia mutations in the LDLR and APOB genes in a subset of the affected family members. Separately, high Lp(a) levels observed in one branch of the family were explained primarily by the LPA locus, including short (<23) Kringle IV repeats and rs3798220.

Conclusions: Taken together, some forms of FH may be explained by family-specific combinations of LDL-C GWAS SNPs.

Keywords: Familial hypercholesterolemia (FH); Genetic risk score (GRS); LDL cholesterol; Lipoprotein (a).

MeSH terms

  • Apolipoprotein B-100 / genetics
  • Austria
  • Biomarkers / blood
  • Cholesterol / blood*
  • DNA Mutational Analysis
  • Exome Sequencing
  • Female
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Heredity
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / diagnosis
  • Hyperlipoproteinemia Type II / genetics*
  • Lipoprotein(a) / blood
  • Lipoprotein(a) / genetics
  • Male
  • Middle Aged
  • Mutation*
  • Pedigree
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Receptors, LDL / genetics
  • Risk Factors

Substances

  • APOB protein, human
  • Apolipoprotein B-100
  • Biomarkers
  • LDLR protein, human
  • Lipoprotein(a)
  • Receptors, LDL
  • Cholesterol